FDA inspection
Shanghai Ambiopharm Inc.: FDA inspection ending Jan 29, 2016
FDA inspection 959934 · No Action Indicated (NAI) · Shanghai
Key facts
| Inspection ID | 959934 |
|---|---|
| Firm | Shanghai Ambiopharm Inc. |
| FEI number | 3006494603 |
| Address | No. 388 Chugong Lu, Fengxian |
| City | Shanghai |
| Country | China |
| Fiscal year | 2016 |
| Inspection end date | Jan 29, 2016 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data